A Phase 2, Randomized, Placebo-Controlled, Double-Masked Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRX, and Antisense Inhibitor of Complement Factor B, in Patients with Geographic Atrophy Secondary to Age-Related Macular Degeneration.
Principal Investigator – Dr. Fred Chen
For further information contact the Clinical Trials Office on (08) 9381 0750 or email clinicalresearch@lei.org.au
